Sign up for our newsletter and get 20% off your first order!

Research

Pharmaceutical Journal

Approved and reviewable research records from Pharmaceutical Journal.

Royal Pharmaceutical SocietyPeer reviewedJournal website

RT3

Phase III retatrutide study demonstrates 30% weight loss

2026

DOI 10.1211/pj.2026.1.413195human

Open source record

RT3

Health news round-up: Alzheimer's treatment, retatrutide results and kidney cancer guidelines

2026

DOI 10.1211/pj.2026.1.404547unknown

Open source record